Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

The goal of this clinical trial, led by UCSF researcher Dr. Laura Esserman, is to help patients avoid debilitating treatments like surgery through "watchful waiting."

This trial focuses on a specific type of breast cancer known as Ductal Carcinoma In Situ (DCIS).

"DCIS itself is not life-threatening. It's a window of opportunity to figure out how to prevent you from getting invasive cancer," said Esserman.

DCIS develops in the milk ducts of the breast and is often called "Stage 0" breast cancer.

According to the National Breast Cancer Foundation, 20-25% of all breast cancers are consider

See Full Page